Recombinant multi-species Tenascin-X/TNXB protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Tenascin-X/TNXB protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the tenascin family of extracellular matrix glycoproteins. The tenascins have anti-adhesive effects, as opposed to fibronectin which is adhesive. This protein is thought to function in matrix maturation during wound healing, and its deficiency has been associated with the connective tissue disorder Ehlers-Danlos syndrome. This gene localizes to the major histocompatibility complex (MHC) class III region on chromosome 6. It is one of four genes in this cluster which have been duplicated. The duplicated copy of this gene is incomplete and is a pseudogene which is transcribed but does not encode a protein. The structure of this gene is unusual in that it overlaps the CREBL1 and CYP21A2 genes at its 5' and 3' ends, respectively. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
The Alternative Names of target: EDS3,EDSCLL,EDSCLL1,HXBL,Hexabrachion-like protein,TENX,TN-X,TNX,TNXB,TNXB1,TNXB2,TNXBS,Tenascin-X,Tn-mhc,Tnx,Tnxb,VUR8,XB,XBS
Go
to Tenascin-X/TNXB products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-SE0520-Ag-1/ GM-Tg-hg-SE0520-Ag-2 | Human Tenascin-X/TNXB protein | Human |
| GM-Tg-rg-SE0520-Ag-1/ GM-Tg-rg-SE0520-Ag-2 | Rat Tenascin-X/TNXB protein | Rat |
| GM-Tg-mg-SE0520-Ag-1/ GM-Tg-mg-SE0520-Ag-2 | Mouse Tenascin-X/TNXB protein | Mouse |
| GM-Tg-cynog-SE0520-Ag-1/ GM-Tg-cynog-SE0520-Ag-2 | Cynomolgus/Rhesus macaque Tenascin-X/TNXB protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-SE0520-Ag-1/ GM-Tg-felg-SE0520-Ag-2 | Feline Tenascin-X/TNXB protein | Feline |
| GM-Tg-cang-SE0520-Ag-1/ GM-Tg-cang-SE0520-Ag-2 | Canine Tenascin-X/TNXB protein | Canine |
| GM-Tg-bovg-SE0520-Ag-1/ GM-Tg-bovg-SE0520-Ag-2 | Bovine Tenascin-X/TNXB protein | Bovine |
| GM-Tg-equg-SE0520-Ag-1/ GM-Tg-equg-SE0520-Ag-2 | Equine Tenascin-X/TNXB protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-SE0520-Ag-1/ GM-Tg-hg-SE0520-Ag-2;
GM-Tg-rg-SE0520-Ag-1/ GM-Tg-rg-SE0520-Ag-2;
GM-Tg-mg-SE0520-Ag-1/ GM-Tg-mg-SE0520-Ag-2; GM-Tg-cynog-SE0520-Ag-1/ GM-Tg-cynog-SE0520-Ag-2; GM-Tg-felg-SE0520-Ag-1/ GM-Tg-felg-SE0520-Ag-2; GM-Tg-cang-SE0520-Ag-1/ GM-Tg-cang-SE0520-Ag-2; GM-Tg-bovg-SE0520-Ag-1/ GM-Tg-bovg-SE0520-Ag-2; GM-Tg-equg-SE0520-Ag-1/ GM-Tg-equg-SE0520-Ag-2 |
| Products Name | Tenascin-X/TNXB protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | Tenascin-X/TNXB |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Tenascin-X/TNXB protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.